Lash GE

No ORCID on file · 5 papers in corpus · active 2024-2025

Study types

  • review 2
  • article 1

Condition tags

  • endometriosis 2
  • infertility 1
2025
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) ·doi:10.1097/fm9.0000000000000311

ObjectiveTo evaluate the early pregnancy loss (EPL) rates in women with and without low molecular weight heparin (LMWH) treatment during early pregnancy.MethodsA retrospective, non-randomized study was conducted at Guangzhou Women and Child…

review 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01413-z

Endocrine disrupting chemicals (EDCs) are ubiquitous in the environment and have been shown to interfere with the endocrine system, leading to adverse effects on reproductive health. In females, EDC exposure has been linked to menstrual irr…

review 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1526709

Metformin, the most widely used anti-diabetic drug, has been demonstrated to exert various effects, including antioxidant, anti-inflammatory, anti-tumor, and cardioprotective properties. Due to its affordability and low toxicity profile, me…

article 2025
Cell reports. Medicine ·doi:10.1016/j.xcrm.2025.102464

Endometriosis-associated ovarian carcinoma (EAOC) predominantly arises from the malignant transformation of endometriomas, yet the mechanism is incompletely defined. Spatial transcriptomic analysis of human specimens of normal endometrium, …

2024
Journal of ovarian research ·doi:10.1186/s13048-024-01434-z

Abnormal granulosa cell (GC) death contributes to cyclophosphamide (CTX) induced primary ovarian insufficiency (POI). To investigate the contribution of GCs to POI, gene profiles of GCs exposed to CTX were assessed using RNA-Seq and bioinfo…